PATENT CLAIM ANALYSIS

Application Number: 15876553
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "282000"]

Abstract:
The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.

Claim (Index 19):
The liquid spray formulation of claim  24 , wherein the antioxidant is sodium ascorbate.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 2.09524
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15601331', '14730585', '14923630', '14576357', '15589090']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7973560280238451
- 35 USC 102 Novelty (BERT): 0.5498490404842145
- Combined Prediction Score: 0.7726053292698821
- Mean Citation Score: 343.90407000000016
- Max Citation Score: 450.5875
- Similarity Product: 259.45016322806475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test